An underground economy for unapproved slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on recent findings.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which remains in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Viewers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.
Active Trade on Messaging Platforms
Additionally, a flourishing market exists on messaging services, where communities with thousands of members share “before and after” images, injection guides and assertions of rapid UK delivery. Vendors promote the drug there before redirecting customers to other platforms for purchases.
Learning About The Experimental Drug
This medication is an experimental injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Express Worries
However, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is worrisome and could result in users injecting products of uncertain source.
Some experts stated the demand for retatrutide could be linked to the rising price of approved weight loss products such as Mounjaro.
Legal Status and Enforcement
Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.
Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and distribution can still breach medicines, marketing, and consumer laws, risking fines, prosecution or imprisonment.
Service Reaction and Content Removal
Based on the social media company, the service has taken down violative content and prohibited related keywords and query recommendations. The organization said it was committed to keeping the platform safe and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Investigations also found communities with up to 9,000 members selling the experimental drug using Telegram's integrated discovery tool, which operates like a online catalog. Typing “retatrutide” instantly displays channels with numerous of users, populated with photos of weight loss, glowing reviews and step-by-step guides for preparing or administering at residence.
After minutes of entering one community, a seller posted WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and promised delivery within 48 hours. When questioned whether the substance was authentic, one vendor said: “You can’t be sure.” Another provided a photo of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.
Product Information and Pricing
Inside these groups, posts show black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled injectors typically sold at £160 for 20mg. When asked how long a injector should be used, sellers give contradictory answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Actions
A representative for the messaging service stated it regularly monitored harmful material on its platform including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“People are injecting materials they can’t verify. Although the research behind this drug is valid, these online products may not contain what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.
A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for approved weight-loss drugs such as Mounjaro. “With costs rising, individuals are using social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was sterile,” she said.
Her team has previously seen individuals harmed by self-injection from unverified sources. “We recognize the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to possibly significant medical dangers”.
